GET THE APP

The Effect of Obesity on the Diagnosis and Treatment of Breast Cancer
..

Archives of Surgical Oncology

ISSN: 2471-2671

Open Access

Short Communication - (2023) Volume 9, Issue 2

The Effect of Obesity on the Diagnosis and Treatment of Breast Cancer

Marie Jeanne*
*Correspondence: Marie Jeanne, Department of Surgical Oncology, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, Netherlands, Email:
Department of Surgical Oncology, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, Netherlands

Received: 08-Dec-2022, Manuscript No. ASO-22-82821 ; Editor assigned: 12-Dec-2022, Pre QC No. ASO-22-82821 (PQ); Reviewed: 27-Dec-2022, QC No. ASO-22-82821 ; Revised: 03-Mar-2023, Manuscript No. ASO-22-82821 (R); Published: 13-Mar-2023 , DOI: 10.37421/2471-2671.2023.9.35
Citation: Jeanne, Marie. "The Effect of Obesity on the Diagnosis and Treatment of Breast Cancer." Arch Surg Oncol 9 (2023): 35.
Copyright: © 2023 Jeanne M. This is an open-access article distributed under the terms of the creative commons attribution license which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Abstract

One of the most common types of cancer is breast cancer. Pathological image processing of the breast has emerged as a significant method for early breast cancer diagnosis. In the field of medical image diagnosis, the use of medical image processing to help doctors detect potential breast cancer as soon as possible has always been a hot topic. In this paper, a bosom disease acknowledgment strategy in light of picture handling is efficiently explained from four perspectives: Image fusion, image segmentation, image registration, and breast cancer detection in the context of breast cancer examination, the accomplishments and application scope of supervised learning, unsupervised learning, deep learning, CNN, and other methods are discussed. The possibility of unaided learning and move learning for bosom malignant growth conclusion is prospected. Finally, patients with breast cancer should have their privacy protected.

Keywords

Progesterone receptor • Breast cancer • Endocrine therapy • Bosom disease • 3-kinase (PI3K) pathway

Introduction

Arteaga and colleagues discuss the role that mutations in the phosphatidylinositol 3-kinase (PI3K) pathway play in the progression of breast cancer and its response to treatment in our second review [1-3]. PI3K is the most frequently mutated pathway in breast cancer because it is a major signaling hub downstream of HER2/neu and other receptor tyrosine kinases, and mutations in the genes that make up this pathway occur in more than 70% of cases [4]. In addition, it is now understood that activation of the PI3K pathway is a significant molecular factor that determines resistance to anti-estrogen therapies in estrogen receptor positive breast cancers and resistance to HER2/neu-targeted therapies in HER2/neuamplified breast cancers. Breast cancer related alterations in the PI3K pathway, their connection to therapeutic resistance, and the state of clinical development of PI3K pathway inhibitors are all examined by Arteaga and colleagues. They do this by presenting an excellent model for the integration and application of research in fundamental molecular genetics to clinical oncology.

Steroid hormones and the receptors for them regulate a wide range of biological functions, including the development of sex organs, pregnancy, bone density, cholesterol mobilization, brain function, and the cardiovascular system, among other things. They also play a significant role in the progression of breast cancer. Hormone receptor positive breast cancer accounts for nearly 70% of cases. Their cells have positive articulation of emergency room and additionally PR, which are connected with disease cell development and spread. PR is an up-regulated target gene of ER, its expression is dependent on estrogen, and PR can modulate ER action. PR is also a valuable prognostic biomarker of overall survival or Disease-Free Survival (DFS) in breast cancer. Estrogen and its receptor, ER, play a crucial role in the development and progression of the disease. We will focus on PR's role in breast cancer subtype, prognosis, treatment, and endocrine therapy in this review [5].

Description

The course of breast cancer is influenced by obesity from the moment of diagnosis. Women who are overweight or obese are less likely to follow screening recommendations like mammography and to stick to healthy lifestyle choices. A meta-analysis of 16 studies looked at the relationship between BMI and mammography in women over 40. It found that overweight women were less likely to have had a mammogram in the past two years than women of normal weight. This was especially true for Caucasian and women with the highest BMI, but not for African American women. In taking a gander at hindrances to screening to mammography in ladies matured 50-69, a Kaiser permanente investigation discovered that resistance was higher in corpulent ladies and that they were two times as liable to refer to torment with the system as a justification for rebelliousness [6].

A combination of modalities can be used to administer neo-adjuvant chemotherapy. In stage II neo-adjuvant preliminary, a mix of docetaxel and epirubicin was assessed for movement and harmfulness in ladies with enormous, operable or privately progressed (stage III) bosom carcinoma, as well as patients with provocative bosom carcinoma. The trial's observed response rate was 76.7%, according to the results. Clinically significant diarrhoea was experienced by more than 25% of the patients, grade 4 neutropenia was experienced by 80%, and febrile neutropenia was experienced by one third of the patients. Patients were able to finish the planned treatment when prophylactic hemopoietic growth factor support was used later. The specialists presumed that neo-adjuvant epirubicin in addition to docetaxel was dynamic and attainable for patients with bosom carcinoma incorporating patients with horrible sickness introductions like privately progressed bosom carcinoma and fiery bosom carcinoma.

The initial practice test for image fusion is image registration. Multiple modes or modes of image registration and fusion are required for clinical breast cancer diagnosis. Doctors can make more accurate diagnoses with more information. Medical image registration is primarily used in the breast cancer clinical diagnosis process to locate reference points in two or more images; the location of the reference point in a coordinate system is determined by spatial location transformation, such as rotation. Enlistment expects that the planning of focuses between pictures is coordinated correspondence; that is, there are points in one image space that correspond to points in another image space. In the context of medical diagnosis, this means that the points in an image can correspond precisely or roughly. There are two kinds of registration: based on both external and internal characteristics. The focus of registration algorithm research is noninvasive and traceable registration based on internal image features.

During breast carcinogenesis, precancerous lesions and mammary tumors are characterized by an increase in the proportion of proliferating ER/PR positive cells and a shift from paracrine to autocrine steroid hormone regulation. During breast tumorigenesis, there was an increase in the number of cells that expressed both the ER and the Ki proliferation associated antigen. Is it the crucial step that leads to ductal carcinoma in situ or invasive breast cancer from hyperplasia? Is it necessary for the development of hormone-negative breast cancer? BRCA1 can inhibit PR transcriptional activity by ubiquitination, resulting in PR degradation and epigenetic silencing of target promoters. BRCA1 driven triple-negative breast cancer has been shown to arise from luminal progenitors, and previous research indicated that breast cancer with the harmful breast cancer 1 (BRCA1) variant is more likely to be hormone receptor negative.

Conclusion

While little series from individual malignant growth places have announced equivalent paces of careful difficulties in stout and ordinary weight ladies going through mastectomy, bigger series which incorporate various establishments propose in any case. Obesity was found to be linked to an increased risk of both minor and major surgical complications, specifically bleeding complications and surgical site infections, according to recent data from the ACS-NSQIP database, which included 7202 women.

References

arrow_upward arrow_upward